© 2026 Copyright Enamine
Back
Product details:
CAS
877399-52-5
Purity
95%
Crizotinib is a receptor tyrosine kinase inhibitor used to treat metastatic non-small cell lung cancer (NSCLC) where the tumors have been confirmed to be anaplastic lymphoma kinase (ALK), or ROS1-positive.
Properties
Name
Crizotinib
Smiles
C[C@@H](OC=1C=C(C=NC1N)C=2C=NN(C2)C3CCNCC3)C=4C(Cl)=CC=C(F)C4Cl
Targets
Please log in to see this information
Sold for research purposes under agreement from Pfizer Inc.
SDS
(R)-crizotinib | CZT | PF-02341066 | PF-2341066 | Xalkori | critozinib | crizotinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
(R)-crizotinib | CZT | PF-02341066 | PF-2341066 | Xalkori | critozinib | crizotinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:
0
CAS:1374356-45-2
0
